Cardiac troponin T for early detection of cardiotoxicity in breast cancer patients treated with epirubicin

Cardiac troponin T for early detection of cardiotoxicity in breast cancer patients treated with epirubicin

Bibliographic Details
Main Authors:	Erdim Refik, Celiker Aydin, Gemici Gökmen, Tokay Sena, Ülfer Gözde, Dede Fuat, Turhal Serdar, Oktay Ahmet
Format:	Article
Language:	English
Published:	De Gruyter 2009-09-01
Series:	Open Medicine
Subjects:	breast cancer chemotherapy epirubicin cardiotoxicity ctnt
Online Access:	https://doi.org/10.2478/s11536-008-0093-z

Similar Items

Protective effect of propolis from Tigzirt on epirubicin-induced cardiotoxicity and nephrotoxicity.
by: Sara Chaa, et al.
Published: (2021-07-01)

<i>POLRMT</i> as a Novel Susceptibility Gene for Cardiotoxicity in Epirubicin Treatment of Breast Cancer Patients
by: Alejandro Velasco-Ruiz, et al.
Published: (2021-11-01)

Epirubicin Alters DNA Methylation Profiles Related to Cardiotoxicity
by: Nhan Nguyen, et al.
Published: (2022-06-01)

Effect of Epirubicin Against Glioma Initiating Cells
by: Atsushi Nakajima, et al.
Published: (2020-11-01)

Protective Effects of Hesperetin on Cardiomyocyte Integrity and Cytoskeletal Stability in a Murine Model of Epirubicin-Induced Cardiotoxicity: A Histopathological Study
by: Adina Pop Moldovan, et al.
Published: (2024-03-01)

A Hydrogel-Based Epirubicin Delivery System for Intravesical Chemotherapy
by: Ching-Wen Liu, et al.
Published: (2016-06-01)

Efficacy and Safety of Epirubicin Combined with Temozolomide for Treatment of Advanced Leiomyosarcoma
by: Tan H, et al.
Published: (2021-12-01)

Polyphosphazene-Based Nanocarriers for the Release of Camptothecin and Epirubicin
by: Javier Pérez Quiñones, et al.
Published: (2022-01-01)

CHEMOTHERAPY CARDIOTOXICITY SCREENING WITH CARDIAC TROPONINS
by: O. V. Krikunova, et al.
Published: (2015-12-01)

Involvement of intracellular cAMP in epirubicin-induced vascular endothelial cell injury
by: Takaaki Yamada, et al.
Published: (2016-01-01)

Cardiorespiratory Fitness and Highly Sensitive Cardiac Troponin Levels in a Preventive Medicine Cohort
by: Laura F. DeFina, et al.
Published: (2016-12-01)

A Physiologically Based Pharmacokinetic Model to Predict Determinants of Variability in Epirubicin Exposure and Tissue Distribution
by: Radwan Ansaar, et al.
Published: (2023-04-01)

Epirubicin-induced Kounis syndrome
by: Hui-zhu Liang, et al.
Published: (2021-03-01)

Ventricular function and high-sensitivity cardiac troponin T in preterm infants with neonatal sepsis
by: Nusarintowati Ramadhina, et al.
Published: (2015-07-01)

Metformin Alleviates Epirubicin-Induced Endothelial Impairment by Restoring Mitochondrial Homeostasis
by: Qi Sun, et al.
Published: (2022-12-01)

Lysine Decorated Solid Lipid Nanoparticles of Epirubicin for Cancer Targeting and Therapy
by: Parvaneh Bayat, et al.
Published: (2021-01-01)

Circulating Levels of Epirubicin Cause Endothelial Senescence While Compromising Metabolic Activity and Vascular Function
by: Amanda J. Eakin, et al.
Published: (2020-08-01)

Clinical outcome and predictive factors for docetaxel and epirubicin neoadjuvant chemotherapy of locally advanced breast cancer
by: Hye Sung Won, et al.
Published: (2020-11-01)

High-Sensitivity Cardiac Troponin T in Prediction and Diagnosis of Early Postoperative Hypoxemia after Off-Pump Coronary Artery Bypass Grafting
by: Peng Lu, et al.
Published: (2022-11-01)

Sensitive and Selective Electrochemical Detection of Epirubicin as Anticancer Drug Based on Nickel Ferrite Decorated with Gold Nanoparticles
by: Mohammad Mehmandoust, et al.
Published: (2021-10-01)

The Fate of Sialic Acid and PEG Modified Epirubicin Liposomes in Aged versus Young Cells and Tumor Mice Models
by: Dezhi Sui, et al.
Published: (2022-02-01)

Poly-(Lactic-co-Glycolic) Acid Nanoparticles for Synergistic Delivery of Epirubicin and Paclitaxel to Human Lung Cancer Cells
by: Nikita Sharma, et al.
Published: (2020-09-01)

One-Pot Synthesis of Epirubicin-Capped Silver Nanoparticles and Their Anticancer Activity against Hep G2 Cells
by: Jun Ding, et al.
Published: (2019-03-01)

Effect of metformin alone and in combination with etoposide and epirubicin on proliferation, apoptosis, necrosis, and migration of B-CPAP and SW cells as thyroid cancer cell lines
by: Ghazaleh Ghavami, et al.
Published: (2023-01-01)

Exercise-Induced Ventricular Fibrillation: Seven Years Follow-Up
by: Gökmen Gemici, et al.
Published: (2011-11-01)

Effects of HepaSphere microsphere encapsule epirubicin with a new loading method transarterial chemoembolization: in vitro and in vivo experiments
by: Wen Zhang, et al.
Published: (2023-11-01)

The effect of mesoporous silica nanoparticles loaded with epirubicin on drug-resistant cancer cells
by: Mohammad Yahya Hanafi-Bojd, et al.
Published: (2017-07-01)

Cardiac Troponins: Contemporary Biological Data and New Methods of Determination
by: Chaulin A
Published: (2021-06-01)

Differential immunomodulatory effects of epirubicin/cyclophosphamide and docetaxel in breast cancer patients
by: Kerstin Wimmer, et al.
Published: (2023-11-01)

Dopamine-conjugated apoferritin protein nanocage for the dual-targeting delivery of epirubicin
by: Hasanain Gomhor J. Alqaraghuli, et al.
Published: (2019-10-01)

The Value of Troponin as a Biomarker of Chemotherapy-Induced Cardiotoxicity
by: Victorita Sorodoc, et al.
Published: (2022-08-01)

Ursolic Acid Enhances the Sensitivity of MCF-7 and MDA-MB-231 Cells to Epirubicin by Modulating the Autophagy Pathway
by: Zhennan Wang, et al.
Published: (2022-05-01)

Developed and validated stability indicating HPLC method for the determination of epirubicin in bulk drug, marketed injection and polymeric nanoparticles
by: Mohammad Tariq, et al.
Published: (2019-04-01)

Hybrid System for Local Drug Delivery and Magnetic Hyperthermia Based on SPIONs Loaded with Doxorubicin and Epirubicin
by: Dorota Nieciecka, et al.
Published: (2021-04-01)

Destruction of vasculogenic mimicry channels by targeting epirubicin plus celecoxib liposomes in treatment of brain glioma
by: Ju RJ, et al.
Published: (2016-03-01)

Transcriptional upregulation of c‐MYC by AXL confers epirubicin resistance in esophageal adenocarcinoma
by: Jun Hong, et al.
Published: (2018-12-01)

Melatonin protects against Epirubicin-induced ovarian damage
by: Naiqiang WANG, et al.
Published: (2019-11-01)

Development of Epirubicin-Loaded Biocompatible Polymer PLA–PEG–PLA Nanoparticles: Synthesis, Characterization, Stability, and In Vitro Anticancerous Assessment
by: Salam Massadeh, et al.
Published: (2021-04-01)

Development of R8 modified epirubicin–dihydroartemisinin liposomes for treatment of non-small-cell lung cancer
by: Jing-Jing Liu, et al.
Published: (2019-12-01)

Core-shell iron oxide-platinium@metal organic framework/epirubicin nanospheres: Synthesis, characterization and anti-breast cancer activity
by: Jiadi Li, et al.
Published: (2023-11-01)